Linked Life Data

14664177

Source:http://linkedlifedata.com/resource/pubmed/id/14664177

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2003-12-10
pubmed:abstractText
Effectiveness of glucocorticoid and cyclophosphamide pulse-therapy was studied in patients with thrombangitis abliterans (TA). We examined 28 males. All of them were treated with antiplatelet agents and vasodilators in standard doses. In addition, 16 patients received a standard three-day scheme of a glucocorticoid and cyclophosphamide pulse-therapy. The examination of the patients was carried out before the treatment and in a month. Estimation of clinical activity was made according to the BVAS index, serum levels of C-reactive protein (CRP) and von Willebrand factor antigen (VWF-Ag), ESR. Before the start of the treatment there were no significant differences in the values of BVAS, ESR and CRP between the groups. In a month, BVAS index, concentrations, the rate of high serum levels of CRP and frequency of amputations were significantly reduced in patients treated with pulse-therapy. So, this pulse-therapy has a considerable anti-inflammatory effect and decreases frequency of amputations in thrombangiitis obliterans.
pubmed:language
rus
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0023-2149
pubmed:author
pubmed:issnType
Print
pubmed:volume
81
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
53-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
[Pulse-therapy with glucocorticoids and cyclophosphamide in the treatment of thromboangiitis obliterans].
pubmed:publicationType
Journal Article, English Abstract